You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV-1 capsid inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

Not yet recruiting
  • HIV Infections
  • Teropavimab
  • +4 more
  • (no location specified)
Feb 6, 2023

HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

Active, not recruiting
  • HIV-1 Infection
  • Oral Lenacapavir
  • +3 more
  • Los Angeles, California
  • +22 more
Nov 4, 2022

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

HIV Trial in Worldwide (VH4004280, VH4011499, VH4004280 Matching Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +42 more
Sep 12, 2023

HIV Trial in Las Vegas (VH4004280, Placebo)

Recruiting
  • HIV Infections
  • Las Vegas, Nevada
    GSK Investigational Site
Jan 6, 2023

HIV-1-infection Trial in Worldwide (Oral Lenacapavir, Oral Lenacapavir Placebo, Subcutaneous Lenacapavir)

Active, not recruiting
Has Results
  • HIV-1-infection
  • Oral Lenacapavir
  • +4 more
  • Los Angeles, California
  • +74 more
Oct 17, 2022

HIV Trial in Las Vegas (VH4011499, Placebo)

Recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Jan 5, 2023

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
Has Results
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

HIV Disease Trial in New York (alpha-1-Proteinase Inhibitor)

Completed
Has Results
  • HIV Disease
  • alpha-1-Proteinase Inhibitor
  • New York, New York
    Cabrini Medical Center
Aug 31, 2021

HIV-1 Trial in Panama, South Africa, United States (F/TAF, 3rd ARV agent, Boosted PIs)

Active, not recruiting
Has Results
  • HIV-1
  • Los Angeles, California
  • +7 more
Nov 11, 2022

HIV-1-infection Trial in Johannesburg (Doravirine/Lamivudine/Tenofovir)

Recruiting
  • HIV-1-infection
  • Johannesburg, Gauteng, South Africa
  • +2 more
Jun 6, 2022

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV-1 Infection Trial (Doravirine/lamivudine/tenofovir disoproxil fumarate)

Completed
Has Results
  • HIV-1 Infection
  • Doravirine/lamivudine/tenofovir disoproxil fumarate
  • (no location specified)
Oct 7, 2021

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

Completed
Has Results
  • Human Immunodeficiency Virus Type 1
  • Phoenix, Arizona
  • +81 more
Nov 25, 2021

HIV Trial in United States (Fosamprenavir, Lopinavir/Ritonavir, Ritonavir)

Completed
  • HIV Infections
  • Los Angeles, California
  • +12 more
Oct 28, 2021

HIV Trial in Puerto Rico, United States (Enfuvirtide)

Completed
  • HIV Infections
  • La Jolla, California
  • +24 more
Oct 28, 2021

HIV Trial in United States (SCH-D (vicriviroc), Placebo)

Completed
  • HIV Infections
  • SCH-D (vicriviroc)
  • Placebo
  • Los Angeles, California
  • +29 more
Oct 28, 2021

HIV Trial in Hangzhou, Beijing, Shanghai (Oral CAB, CAB LA)

Completed
Has Results
  • HIV Infections
  • Oral CAB
  • CAB LA
  • Hangzhou, Zhejiang, China
  • +2 more
May 12, 2021

HIV-1-infection Trial in Kampala, Harare (GS-9131, BIC, TAF)

Terminated
Has Results
  • HIV-1-infection
  • Kampala, Uganda
  • +1 more
Dec 7, 2020

HIV-1 Infection Trial in United States (Lenacapavir, Placebo, B/F/TAF)

Completed
Has Results
  • HIV-1 Infection
  • Los Angeles, California
  • +11 more
Mar 16, 2021

HIV-1-infection Trial in United States (Albuvirtide, 3BNC117, Baseline ART)

Recruiting
  • HIV-1-infection
  • Palm Springs, California
  • +6 more
Sep 28, 2021

HIV Disease Trial in New York (a1 Proteinase Inhibitor, Placebos)

Terminated
Has Results
  • HIV Disease
  • α1 Proteinase Inhibitor
  • Placebos
  • New York, New York
    ACRIA
Aug 22, 2020

HIV Infection Trial in Worldwide (DTG +DRV/r, SOC)

Completed
  • HIV Infection
  • Buenos Aires, Argentina
  • +30 more
Mar 25, 2021

HIV Trial in Worldwide (DTG, LPV/RTV, Two NRTIs)

Completed
Has Results
  • HIV Infections
  • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • +58 more
Feb 23, 2022